NYSE:IPHI - Inphi Stock Price, Forecast & News

Inphi trades on the New York Stock Exchange (NYSE) under the ticker symbol "IPHI."

Inphi Co. (NYSE:IPHI) announced its quarterly earnings data on Tuesday, October, 29th. The semiconductor company reported $0.45 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.37 by $0.08. The semiconductor company earned $94.23 million during the quarter, compared to analysts' expectations of $90.09 million. Inphi had a positive return on equity of 0.46% and a negative net margin of 23.23%. The company's quarterly revenue was up 20.8% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.30 EPS. View Inphi's Earnings History.

Inphi is scheduled to release their next quarterly earnings announcement on Tuesday, February 4th 2020. View Earnings Estimates for Inphi.

Inphi issued an update on its fourth quarter earnings guidance on Tuesday, October, 29th. The company provided EPS guidance of $0.40-0.50 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.43. The company issued revenue guidance of $97.8-101.8 million, compared to the consensus revenue estimate of $95.35 million.

14 analysts have issued 12 month price objectives for Inphi's shares. Their forecasts range from $45.00 to $95.00. On average, they anticipate Inphi's stock price to reach $71.00 in the next twelve months. This suggests a possible upside of 1.2% from the stock's current price. View Analyst Price Targets for Inphi.

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Inphi in the last year. There are currently 1 sell rating, 3 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Inphi.

News coverage about IPHI stock has trended somewhat negative this week, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Inphi earned a coverage optimism score of -1.5 on InfoTrie's scale. They also gave news articles about the semiconductor company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for Inphi.

Inphi saw a drop in short interest in the month of October. As of October 31st, there was short interest totalling 4,560,000 shares, a drop of 13.6% from the September 30th total of 5,280,000 shares. Based on an average daily trading volume, of 924,000 shares, the short-interest ratio is presently 4.9 days. Currently, 10.3% of the company's stock are short sold. View Inphi's Current Options Chain.

Some companies that are related to Inphi include Intel (INTC), NVIDIA (NVDA), Broadcom (AVGO), Texas Instruments (TXN), Micron Technology (MU), Analog Devices (ADI), Xilinx (XLNX), Microchip Technology (MCHP), Skyworks Solutions (SWKS), Marvell Technology Group (MRVL), Maxim Integrated Products (MXIM), Cypress Semiconductor (CY), Monolithic Power Systems (MPWR), First Solar (FSLR) and Cree (CREE).

Based on aggregate information from My MarketBeat watchlists, some companies that other Inphi investors own include NVIDIA (NVDA), Alibaba Group (BABA), salesforce.com (CRM), CVS Health (CVS), Veeva Systems (VEEV), Micron Technology (MU), Cisco Systems (CSCO), QUALCOMM (QCOM), Broadcom (AVGO) and Intel (INTC).

Inphi's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include State Street Corp (2.52%), Millennium Management LLC (1.01%), Maverick Capital Ltd. (1.00%), Stephens Investment Management Group LLC (0.53%), Stifel Financial Corp (0.45%) and Kornitzer Capital Management Inc. KS (0.35%). Company insiders that own Inphi stock include Charles Roach, Chenming Hu, Diosdado P Banatao, Ford Tamer, John Edmunds, Nicholas Brathwaite, Richard Ogawa, Ron Torten, Sam Srinivasan and William J Ruehle. View Institutional Ownership Trends for Inphi.

IPHI stock was sold by a variety of institutional investors in the last quarter, including Alexandria Capital LLC, Squarepoint Ops LLC, Herald Investment Management Ltd, Taylor Frigon Capital Management LLC, Stephens Investment Management Group LLC, Virginia Retirement Systems ET AL, First Trust Advisors LP and WCM Investment Management LLC. Company insiders that have sold Inphi company stock in the last year include Charles Roach, Chenming Hu, Diosdado P Banatao, Ford Tamer, John Edmunds, Nicholas Brathwaite, Richard Ogawa, Ron Torten and William J Ruehle. View Insider Buying and Selling for Inphi.

IPHI stock was acquired by a variety of institutional investors in the last quarter, including Maverick Capital Ltd., Stifel Financial Corp, Columbus Circle Investors, Millennium Management LLC, Voloridge Investment Management LLC, Lisanti Capital Growth LLC, California Public Employees Retirement System and State of New Jersey Common Pension Fund D. Company insiders that have bought Inphi stock in the last two years include Ford Tamer and Sam Srinivasan. View Insider Buying and Selling for Inphi.

Shares of IPHI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of IPHI stock can currently be purchased for approximately $70.16.

Inphi has a market capitalization of $3.20 billion and generates $294.49 million in revenue each year. The semiconductor company earns $-95,750,000.00 in net income (profit) each year or ($0.57) on an earnings per share basis. Inphi employs 580 workers across the globe.View Additional Information About Inphi.

The official website for Inphi is http://www.inphi.com/.

Inphi's mailing address is 2953 Bunker Hill Lane Suite 300, Santa Clara CA, 95054. The semiconductor company can be reached via phone at 408-217-7300 or via email at [email protected]